VRTX Insider Transactions — Page 3
3,822 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Bozic Carmen | EVP and CMO | 2023-09-19 | Sale | 5,651.0 | $351.0 |
| Bozic Carmen | EVP and CMO | 2023-09-05 | Sale | 5,651.0 | $352.66 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-08-23 | Sale | 2,500.0 | $355.0 |
| Kearney Terrence C | Director | 2023-08-10 | Sale | 10,000.0 | $350.0 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-08-10 | Sale | 5,750.0 | $345.79 |
| Sachdev Amit | EVP, Chief Patient Officer | 2023-08-10 | Sale | 10,031.0 | $350.0 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2023-08-09 | Sale | 63.0 | $345.51 |
| Bhatia Sangeeta N. | Director | 2023-08-09 | Sale | 242.0 | $345.51 |
| SACHS BRUCE I | Director | 2023-07-17 | Sale | 3,842.0 | $357.29 |
| SACHS BRUCE I | Director | 2023-07-17 | Sale | 5,711.0 | $356.75 |
| SACHS BRUCE I | Director | 2023-07-17 | Sale | 1,697.0 | $355.54 |
| Kewalramani Reshma | CEO & President | 2023-07-17 | Sale | 7,828.0 | $355.0 |
| Arbuckle Stuart A | EVP, COO | 2023-06-15 | Sale | 8,603.0 | $349.0 |
| Arbuckle Stuart A | EVP, COO | 2023-05-30 | Sale | 82.0 | $329.82 |
| Ambrose Kristen | SVP & Chief Accounting Officer | 2023-05-30 | Sale | 289.0 | $329.82 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-08 | Sale | 2,850.0 | $350.0 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-08 | Sale | 1,125.0 | $349.0 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-05 | Sale | 422.0 | $350.03 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-05 | Sale | 171.0 | $350.3 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-05 | Sale | 708.0 | $349.38 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-03 | Sale | 728.0 | $351.6 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-03 | Sale | 2,053.0 | $350.44 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-03 | Sale | 700.0 | $351.59 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-03 | Sale | 1,800.0 | $350.53 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-03 | Sale | 2,008.0 | $349.22 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-02 | Sale | 169.0 | $353.24 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-02 | Sale | 42.0 | $351.65 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-02 | Sale | 1,411.0 | $350.32 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-02 | Sale | 300.0 | $353.18 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-02 | Sale | 1,505.0 | $350.48 |
| LEIDEN JEFFREY M | Executive Chairman | 2023-05-02 | Sale | 4,645.0 | $349.48 |
| Bhatia Sangeeta N. | Director | 2023-05-02 | Sale | 63.0 | $351.2 |
| Bhatia Sangeeta N. | Director | 2023-05-02 | Sale | 163.0 | $349.82 |
| Bhatia Sangeeta N. | Director | 2023-05-02 | Sale | 120.0 | $348.16 |
| Bhatia Sangeeta N. | Director | 2023-05-02 | Sale | 172.0 | $346.69 |
| Bhatia Sangeeta N. | Director | 2023-05-02 | Sale | 62.0 | $345.93 |
| Kewalramani Reshma | CEO & President | 2023-04-27 | Sale | 38.0 | $340.19 |
| Kewalramani Reshma | CEO & President | 2023-04-27 | Sale | 1,668.0 | $339.43 |
| Kewalramani Reshma | CEO & President | 2023-04-27 | Sale | 1,611.0 | $338.69 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-12 | Sale | 2,625.0 | $327.43 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-12 | Sale | 4,068.0 | $326.45 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-12 | Sale | 874.0 | $325.7 |
| SACHS BRUCE I | Director | 2023-04-12 | Sale | 8,026.0 | $327.48 |
| SACHS BRUCE I | Director | 2023-04-12 | Sale | 10,357.0 | $326.46 |
| SACHS BRUCE I | Director | 2023-04-12 | Sale | 2,917.0 | $325.65 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-04 | Sale | 31.0 | $318.68 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-04 | Sale | 96.0 | $317.65 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-04 | Sale | 90.0 | $316.76 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-04 | Sale | 94.0 | $315.66 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-04 | Sale | 211.0 | $314.22 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-24 | Sale | 1,768.0 | $305.38 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sale | 16.0 | $301.13 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sale | 240.0 | $299.58 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sale | 360.0 | $298.09 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sale | 240.0 | $296.3 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sale | 784.0 | $295.43 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sale | 360.0 | $294.52 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-03-16 | Sale | 264.0 | $301.07 |
| Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-03-16 | Sale | 2,482.0 | $300.54 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-13 | Sale | 62.0 | $296.77 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-13 | Sale | 292.0 | $295.89 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-13 | Sale | 715.0 | $294.52 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-13 | Sale | 1,153.0 | $293.35 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-13 | Sale | 420.0 | $292.41 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-13 | Sale | 24.0 | $288.31 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 102.0 | $294.94 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 27.0 | $293.61 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 185.0 | $292.68 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 541.0 | $291.47 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 30.0 | $289.44 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 327.0 | $288.91 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 515.0 | $287.83 |
| WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sale | 361.0 | $286.64 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-27 | Sale | 20.0 | $289.29 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-27 | Sale | 51.0 | $288.33 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-27 | Sale | 283.0 | $287.2 |
| Arbuckle Stuart A | EVP, COO | 2023-02-27 | Sale | 800.0 | $288.92 |
| Arbuckle Stuart A | EVP, COO | 2023-02-27 | Sale | 400.0 | $287.59 |
| Arbuckle Stuart A | EVP, COO | 2023-02-27 | Sale | 3,834.0 | $287.16 |
| Ambrose Kristen | SVP & Chief Accounting Officer | 2023-02-27 | Sale | 42.0 | $289.63 |
| Ambrose Kristen | SVP & Chief Accounting Officer | 2023-02-27 | Sale | 183.0 | $288.68 |
| Ambrose Kristen | SVP & Chief Accounting Officer | 2023-02-27 | Sale | 982.0 | $287.25 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-27 | Sale | 302.0 | $289.6 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-27 | Sale | 300.0 | $288.74 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-27 | Sale | 3,636.0 | $287.23 |
| Arbuckle Stuart A | EVP, COO | 2023-02-22 | Sale | 200.0 | $296.31 |
| Arbuckle Stuart A | EVP, COO | 2023-02-22 | Sale | 394.0 | $295.38 |
| Arbuckle Stuart A | EVP, COO | 2023-02-22 | Sale | 1,378.0 | $294.29 |
| Arbuckle Stuart A | EVP, COO | 2023-02-22 | Sale | 300.0 | $292.86 |
| Arbuckle Stuart A | EVP, COO | 2023-02-22 | Sale | 129.0 | $291.84 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-21 | Sale | 124.0 | $294.77 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-21 | Sale | 207.0 | $293.83 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-21 | Sale | 145.0 | $292.85 |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-21 | Sale | 4.0 | $291.01 |
| Arbuckle Stuart A | EVP, COO | 2023-02-21 | Sale | 736.0 | $294.58 |
| Arbuckle Stuart A | EVP, COO | 2023-02-21 | Sale | 1,100.0 | $293.74 |
| Arbuckle Stuart A | EVP, COO | 2023-02-21 | Sale | 545.0 | $292.77 |
| Arbuckle Stuart A | EVP, COO | 2023-02-21 | Sale | 21.0 | $291.01 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-21 | Sale | 900.0 | $294.73 |
| ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-21 | Sale | 1,843.0 | $294.03 |